TECNIS ODYSSEY TORIC II IOL DRT150 (REF DRT1500175)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TEC ODYSSEY TOR II SMPCY 17.5D CYL1.50 · Class 3 · Implant
All models of TECNIS ODYSSEY TORIC II IOL (106)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 05050474811300), received between Jul 23, 2025 and Jul 31, 2026 — classified as 3 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Break2
- Device Difficult to Setup or Prepare1
- Ejection Problem1
Patient problems
- Blurred Vision2
- Halo2
- No Clinical Signs, Symptoms or Conditions2
- Visual Disturbances1
- Visual Impairment1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJul 31, 2026Adverse Event Without Identified Device or Use Problem
It was reported that a multifocal toric intraocular lens (IOL) was explanted from the patient's right eye due to suboptimal vision. Prior to explantation, the patient experienced difficulty with both distance and near vision and was unable to drive at night due to halos. The patient experienced a loss of two or more lines of best spectacle-corrected visual acuity (BSCVA), decreasing from a preoperative BSCVA of 20/25 to a postoperative BSCVA of 20/40. Preoperative refraction was reported as -2.75 +1.25 x 180, and postoperative refraction was -1.50 sphere, with an intended target refraction of plano. The patient was not reported to be over-corrected or under-corrected. A history of previous LASIK surgery was reported. The lens was replaced with a non-Johnson & Johnson lens of lower diopter power (17.0D). No patient injury, such as a capsule tear, was reported. No medical intervention, including vitrectomy, sutures, incision enlargement, or medications outside the standard of care, was required, and no planned surgical interventions were reported. The procedure was completed successfully, and the patient was reported to be doing well. The customer indicated that the device did not ca
Patient problems: Halo; Visual Impairment
MAUDE report 50104691 ↗MalfunctionDec 16, 2025Break; Break
IT WAS REPORTED THAT AFTER THE PRELOADED MULTIFOCAL TORIC INTRAOCULAR LENS (IOL) WAS FULLY IMPLANTED IN THE PATIENT'S LEFT EYE, THE IOL WAS FOUND TO HAVE A CRACK IN THE CENTER. THE LENS WAS THEN REMOVED AND REPLACED WITH ANOTHER LENS OF THE SAME MODEL AND DIOPTER. THERE WAS AN EXTRA 5 MINUTE DELAY IN PROCEDURE. THERE WAS NO UNPLANNED SUTURE REQUIRED. IT IS UNKNOWN IF THERE WAS AN INCISION ENLARGEMENT. THE ISSUE DID NOT AFFECT PATIENT'S DAILY ACTIVITIES AND THE PATIENT DID NOT SEEK MEDICAL ATTENTION OR WAS NOT PRESCRIBED WITH MEDICATION OUTSIDE OF STANDARD OF CARE. THE PATIENT HAS FULLY RECOVERED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23824320 ↗InjurySep 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE LENS WAS EXPLANTED DUE TO THE PATIENT EXPERIENCING SEVERE GLARE, HALOS, AND POOR-QUALITY VISION FOLLOWING THE IMPLANTATION OF THE LENS. THE SYMPTOMS WERE DESCRIBED AS VERY SEVERE AND DEBILITATING, IMPACTING THE PATIENT'S ABILITY TO PERFORM ACTIVITIES. THE LENS WAS EXPLANTED AND REPLACED WITH AN UNKNOWN EYHANCE LENS. THERE WAS NO CAPSULE TEAR, UNPLANNED VITRECTOMY, OR USE OF SUTURES REPORTED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Blurred Vision; Halo; Visual Disturbances
MAUDE report 23058985 ↗InjuryAug 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT IMPLANTED WITH TECNIS ODYSSEY SIMPLICITY 17.5 D INTRAOCULAR LENS (IOL) ON (B)(6) 2025 IN THE RIGHT EYE (OD) REPORTED DIFFICULTY READING AND SOME MILD BLURRED VISION AT DISTANCE. THE LENS WAS EXPLANTED DURING SECONDARY SURGERY ON (B)(6) 2025 AND REPLACED WITH SAME MODEL 18 D IOL. THE PROCEDURE DID NOT REQUIRE UNPLANNED INCISION ENLARGEMENT, SUTURES, OR VITRECTOMY, AND THERE WAS NO PROCEDURAL DELAY. THE PATIENT¿S PRE-OPERATIVE BEST CORRECTED VISUAL ACUITY WAS 20/25, AND POST-OPERATIVE VISUAL ACUITY IMPROVED TO 20/20. THE PATIENT WAS FULLY RECOVERED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Blurred Vision
MAUDE report 22913483 ↗MalfunctionJul 23, 2025Break; Device Difficult to Setup or Prepare; Ejection Problem; Break; Device Difficult to Setup or Prepare; Ejection Problem
IT WAS REPORTED THAT THE LEADING HAPTIC ON THE PRELOADED JOHNSON AND JOHNSON (JNJ) INTRAOCULAR LENS (IOL) WAS INVERTED AND EXCESSIVE RESISTANCE WAS FELT WHEN ADVANCING THE IOL. THE DOCTOR NOTICED THE INVERTED HAPTIC UNDER A MICROSCOPE. THERE WAS NO CONTACT WITH THE PRELOADED DEVICE OR IOL. THE PROCEDURE WAS COMPLETED WITH A BACKUP LENS. THERE WERE NO COMPLICATIONS SUCH AS A CAPSULE TEAR, VITRECTOMY OR SUTURES. REPORTEDLY, THE DIRECTIONS FOR USE WERE FOLLOWED. THE PATIENT IS DOING WELL.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22581056 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page